Onchocerciasis

Onchocerciasis or river blindness is the world's second leading infectious cause of blindness. It is caused by Onchocerca volvulus, a Parasitic worm that can live for up to fifteen years in the human body. (From the Wikpedia article Onchocerciasis.)

Download PDF containing detailed information.

Recent Publications on Onchocerciasis:
Onchocerciasis (river blindness). Report from the eighteenth InterAmerican Conference on Onchocerciasis, November 2008. la Societe des Nations = Weekly epidemiological record / Health Section of the Secretariat of the League of Nations Identification of drug resistance before it becomes a public health...	15th October, 2009		Wkly Epidemiol Rec. 2009 Sep 18;84(38):385-9.
Onchocerciasis: elimination is feasible. la Societe des Nations = Weekly epidemiological record / Health Section of the Secretariat of the League of Nations Identification of drug resistance before it becomes a public health...	15th October, 2009		Wkly Epidemiol Rec. 2009 Sep 11;84(37):382-3.
Picture this...Onchocerciasis. Mesothelioma develops most commonly in the pleura, and less frequently in...	10th October, 2009	AFSOC, Hurlburt Field, USA.	J Spec Oper Med. 2009 Winter;9(1):136-44.
Identifying sub-optimal responses to ivermectin in the treatment of River Blindness. Identification of drug resistance before it becomes a public health...	7th October, 2009	Department of Infectious Disease Epidemiology, Imperial College London,	Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16716-21. Epub 2009 Sep 17. DOI Direct Link
Head nodding syndrome and river blindness: a parasitologic perspective. Identification of drug resistance before it becomes a public health...	2nd October, 2009		Epilepsia. 2009 Oct;50(10):2325-6. DOI Direct Link
→View more research publications.

Onchocerciasis Clinical Trials:
Study Evaluating Orally Administered Moxidectin in Subjects With Onchocerca Volvulus Infection

Onchocerciasis Patents:
US Patent No.	Title
7368527	HADDE71 polypeptides
7411051	Antibodies to HDPPA04 polypeptide
7414062	Triazaspiro compounds useful for treating or preventing pain
7416723	Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
7417121	Human G-protein coupled receptor, HGPRBMY39
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Onchocerciasis scientists - we have details of around 366 individuals working on Onchocerciasis .